{
    "xml": "<topic id=\"PHP8542\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/sevoflurane\" basename=\"sevoflurane\" title=\"SEVOFLURANE\">\n<title>SEVOFLURANE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_51\" namespace=\"/interactions/list-of-drug-interactions/anaesthetics-general/anaesthetics-general-volatile-liquids/sevoflurane\">Sevoflurane</xref>\n</p>\n<data name=\"vtmid\">108395008</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_670179538\" title=\"Anaesthetics (volatile liquid)\">Anaesthetics (volatile liquid)</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34598\" title=\"VOLATILE LIQUID ANAESTHETICS\" namespace=\"/drug-classes/volatile-liquid-anaesthetics\">VOLATILE LIQUID ANAESTHETICS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP38814\" outputclass=\"indicationsAndDose\" rev=\"1.17\" parent=\"/drugs/sevoflurane\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Induction of anaesthesia (in oxygen or nitrous oxide&#8211;oxygen)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By inhalation</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 0.5&#8211;1&#8239;%, adjusted according to response, then increased to up to 8&#8239;%, to be administered using specifically calibrated vaporiser.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Maintenance of anaesthesia (in oxygen or nitrous oxide&#8211;oxygen)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By inhalation</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.5&#8211;3&#8239;%, adjusted according to response, to be administered using specifically calibrated vaporiser.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38854\" outputclass=\"importantSafetyInformation\" rev=\"1.9\" parent=\"/drugs/sevoflurane\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Sevoflurane should only be administered by, or under the direct supervision of, personnel experienced in its use, with adequate training in anaesthesia and airway management, and when resuscitation equipment is available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38876\" outputclass=\"cautions\" rev=\"1.7\" parent=\"/drugs/sevoflurane\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Susceptibility to QT-interval prolongation</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38809\" outputclass=\"interactions\" rev=\"1.14\" parent=\"/drugs/sevoflurane\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (anaesthetics, general).</p>\n<p>Sevoflurane can interact with carbon dioxide absorbents to form compound A, a potentially nephrotoxic vinyl ether. However, in spite of extensive use, no cases of sevoflurane-induced permanent renal injury have been reported and the carbon dioxide absorbents used in the UK produce very low concentrations of compound A, even in low-flow anaesthetic systems.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38785\" outputclass=\"sideEffects\" rev=\"1.9\" parent=\"/drugs/sevoflurane\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Cardiac arrest</ph>; <ph outputclass=\"sideEffect\">dystonia</ph>; <ph outputclass=\"sideEffect\">leucopenia</ph>; <ph outputclass=\"sideEffect\">torsade de pointes</ph>; <ph outputclass=\"sideEffect\">urinary retention</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38798\" outputclass=\"pregnancy\" parent=\"/drugs/sevoflurane\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>May depress neonatal respiration if used during delivery.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38880\" outputclass=\"breastFeeding\" parent=\"/drugs/sevoflurane\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Breast-feeding can be resumed as soon as mother has recovered sufficiently from anaesthesia.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38790\" outputclass=\"renalImpairment\" parent=\"/drugs/sevoflurane\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38793\" outputclass=\"patientAndCarerAdvice\" rev=\"1.9\" parent=\"/drugs/sevoflurane\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"adviceAroundDrivingAndOtherTasks\">\n<title>Driving and skilled tasks</title>\n<sectiondiv>\n<p>Patients given sedatives and analgesics during minor outpatient procedures should be very carefully warned about the risk of driving or undertaking skilled tasks afterwards. For a short general anaesthetic the risk extends to <b>at least 24 hours</b> after administration. Responsible persons should be available to take patients home. The dangers of taking <b>alcohol</b> should also be emphasised.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP8542-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/sevoflurane\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75943\" title=\"Inhalation vapour\" namespace=\"/drugs/sevoflurane/inhalation-vapour\">Inhalation vapour</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78539\" namespace=\"/treatment-summaries/general-anaesthesia\" title=\"General anaesthesia\" count=\"2\" rel=\"backlink\">General anaesthesia</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_51\" namespace=\"/interactions/list-of-drug-interactions/anaesthetics-general/anaesthetics-general-volatile-liquids/sevoflurane\" title=\"Sevoflurane\" count=\"1\" rel=\"link\">Sevoflurane</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34598\" namespace=\"/drug-classes/volatile-liquid-anaesthetics\" title=\"VOLATILE LIQUID ANAESTHETICS\" count=\"1\" rel=\"link\">VOLATILE LIQUID ANAESTHETICS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75943\" namespace=\"/drugs/sevoflurane/inhalation-vapour\" title=\"Inhalation vapour\" count=\"1\" rel=\"link\">Inhalation vapour</xref>\n</links>\n</topic>",
    "id": "PHP8542",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/sevoflurane",
    "basename": "sevoflurane",
    "title": "SEVOFLURANE",
    "interactants": [
        {
            "id": "bnf_int_51",
            "label": "Sevoflurane"
        }
    ],
    "vtmid": "108395008",
    "drugClassification": [
        "Anaesthetics (volatile liquid)"
    ],
    "inheritsFromClass": [
        "VOLATILE LIQUID ANAESTHETICS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Induction of anaesthesia (in oxygen or nitrous oxide&#8211;oxygen)",
                        "html": "Induction of anaesthesia (in oxygen or nitrous oxide&#8211;oxygen)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "inhalation"
                    ],
                    "textContent": "By inhalation",
                    "html": "By inhalation"
                },
                "adult": [
                    {
                        "textContent": "Initially 0.5&#8211;1 %, adjusted according to response, then increased to up to 8 %, to be administered using specifically calibrated vaporiser.",
                        "html": "<p>Initially 0.5&#8211;1&#8239;%, adjusted according to response, then increased to up to 8&#8239;%, to be administered using specifically calibrated vaporiser.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Maintenance of anaesthesia (in oxygen or nitrous oxide&#8211;oxygen)",
                        "html": "Maintenance of anaesthesia (in oxygen or nitrous oxide&#8211;oxygen)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "inhalation"
                    ],
                    "textContent": "By inhalation",
                    "html": "By inhalation"
                },
                "adult": [
                    {
                        "textContent": "0.5&#8211;3 %, adjusted according to response, to be administered using specifically calibrated vaporiser.",
                        "html": "<p>0.5&#8211;3&#8239;%, adjusted according to response, to be administered using specifically calibrated vaporiser.</p>"
                    }
                ]
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "textContent": "Sevoflurane should only be administered by, or under the direct supervision of, personnel experienced in its use, with adequate training in anaesthesia and airway management, and when resuscitation equipment is available.",
                "html": "<p>Sevoflurane should only be administered by, or under the direct supervision of, personnel experienced in its use, with adequate training in anaesthesia and airway management, and when resuscitation equipment is available.</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Susceptibility to QT-interval prolongation",
                "html": "Susceptibility to QT-interval prolongation"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (anaesthetics, general).\n\nSevoflurane can interact with carbon dioxide absorbents to form compound A, a potentially nephrotoxic vinyl ether. However, in spite of extensive use, no cases of sevoflurane-induced permanent renal injury have been reported and the carbon dioxide absorbents used in the UK produce very low concentrations of compound A, even in low-flow anaesthetic systems.",
                "html": "<p>Appendix 1 (anaesthetics, general).</p><p>Sevoflurane can interact with carbon dioxide absorbents to form compound A, a potentially nephrotoxic vinyl ether. However, in spite of extensive use, no cases of sevoflurane-induced permanent renal injury have been reported and the carbon dioxide absorbents used in the UK produce very low concentrations of compound A, even in low-flow anaesthetic systems.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Cardiac arrest",
                        "html": "Cardiac arrest",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dystonia",
                        "html": "dystonia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "leucopenia",
                        "html": "leucopenia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "torsade de pointes",
                        "html": "torsade de pointes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "urinary retention",
                        "html": "urinary retention",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "May depress neonatal respiration if used during delivery.",
                "html": "<p>May depress neonatal respiration if used during delivery.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Breast-feeding can be resumed as soon as mother has recovered sufficiently from anaesthesia.",
                "html": "<p>Breast-feeding can be resumed as soon as mother has recovered sufficiently from anaesthesia.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution.",
                "html": "<p>Use with caution.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "adviceAroundDrivingAndOtherTasks": [
            {
                "type": "adviceAroundDrivingAndOtherTasks",
                "textContent": "Patients given sedatives and analgesics during minor outpatient procedures should be very carefully warned about the risk of driving or undertaking skilled tasks afterwards. For a short general anaesthetic the risk extends to at least 24 hours after administration. Responsible persons should be available to take patients home. The dangers of taking alcohol should also be emphasised.",
                "html": "<p>Patients given sedatives and analgesics during minor outpatient procedures should be very carefully warned about the risk of driving or undertaking skilled tasks afterwards. For a short general anaesthetic the risk extends to <b>at least 24 hours</b> after administration. Responsible persons should be available to take patients home. The dangers of taking <b>alcohol</b> should also be emphasised.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75943",
                "label": "Inhalation vapour",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78539",
                "label": "General anaesthesia",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_51",
                "label": "Sevoflurane",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34598",
                "label": "VOLATILE LIQUID ANAESTHETICS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75943",
                "label": "Inhalation vapour",
                "type": "medicinalForm"
            }
        ]
    }
}